Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes

Although the glucose lowering effect of dipeptidyl peptidase-4 (DPP4) inhibitors is well established, several potential serious acute safety concerns have been raised including acute kidney injury, respiratory tract infections, and acute pancreatitis. Using the UK-based Clinical Practice Research Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamble, John-Michael, Donnan, Jennifer R., Chibrikov, Eugene, Twells, Laurie K., Midodzi, William K., Majumdar, Sumit R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181978/
https://www.ncbi.nlm.nih.gov/pubmed/30310100
http://dx.doi.org/10.1038/s41598-018-33483-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181978/
https://www.ncbi.nlm.nih.gov/pubmed/30310100
http://dx.doi.org/10.1038/s41598-018-33483-y

Ejemplares similares